fbpx Skip to main content
Category

Diabetes

Diabetes

Ipragliflozin in Diabetes Patients with NAFLD

SGLT-2is, including ipragliflozin, are an effective therapeutic modality for diabetes patients with NAFLD. Ipragliflozin is also effective in the resolution of NASH and in mediating obesity and glycemic control. Sodium–glucose co-transporter 2 inhibitors (SGLT-2is) are…
October 19, 2022